The NB.1.8.1 variant made up roughly 10.7 per cent of all global infections by late April 2025 – up from just 2.5 per cent ...

Jefferies reaffirms its Buy rating on Pfizer and sticks to a $33 target, calling the stock undervalued at $23.35. Their ...

A new COVID variant - NB 1.8.1 - is creeping across the country; here are the symptoms to watch for, and vaccinations you'll ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A UCLA professor of clinical obstetrics and gynecology says he still sees more bad outcomes in pregnant patients who have ...

Although Pfizer has made some efforts to turn things around, they have been insufficient. Pfizer's poor performance since ...

Makary was accurate when he said that "most countries have stopped recommending" routine COVID-19 vaccination for children.

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...

New COVID variant NB.1.8.1 spreads rapidly worldwide with 6 spike mutations. Learn symptoms, vaccine protection, and safety ...